Research institutes and “centres of excellence” exist around the world to draw talent and to share resources - all with the aim of solving important problems.
One big challenge for gene therapies is delivering DNA or RNA safely to cells inside patients’ bodies. New nanoparticles could be an improvement over the current standard – repurposed viruses.
Biologists’ growing reliance on computers advances the field – but comes with new risks. The first step toward improved cyberbiosecurity is increasing awareness of possible threats.
Scientists and government agencies have been studying biofuel production from algae for years. Research points toward a more affordable and efficient production process that recycles water.
Brain-computer interfacing is a hot topic in the tech world, with Elon Musk’s announcement of his new Neuralink startup. Here, researchers separate what’s science from what’s currently still fiction.
Armed forces around the world are exploring technological and biological enhancements to their soldiers. But this raises a number of serious ethical concerns, before, during and after conflict.
A scientific breakthrough in a vacuum may be free of ethical implications. But many developments can be used for good or evil, or both. There’s a fine balance on what to control and to what extent.
New research works out how to translate between the language of biology – molecules – and the language of microelectronics – electrons. It could open the door to new kinds of biosensors and therapeutics.
Individual light-harvesting protein complexes have a remarkable ability. Light, which is normally effectively harvested, is also used to finely control how much of it should be harvested.
One way to tackle the snakebite antivenom crisis may be through biotechnological innovation to make antivenoms more cost-effective, easier to produce, and more efficacious against snakebites.
Science communication has grown in leaps and bounds over the past 60 years. It plays a crucial role in democratising science and making it less mysterious.
Regulations, funding and public opinion around genetically enhancing future generations vary from country to country. Here’s why China may be poised to be the pioneer.
U.C. Berkeley and the Broad Institute are fighting to control the patents on the revolutionary gene-editing technology. But there’s a lot more at stake than just who gets the credit and licensing fees.
Professor - Emerging Technologies (Stem Cells) at The University of Melbourne and Group Leader - Stem Cell Ethics & Policy at the Murdoch Children's Research Institute, The University of Melbourne